Corporate Partners
Diamond Partners
Abbott Molecular
Platinum Partners
Gold Partners


Silver Partners

Life Technologies



Important Information

AMP 2014 Annual Meeting
November 13 -15, 2014
For More Information

Corporate Workshop Day & Gala, November 12, 2014

Gaylord National Resort & Convention Center
National Harbor, MD (just outside of Washington, DC)

Special Features

AMP International
AMP Test Directory
Awards, Grants & Honors
Career Development
Membership Information
Online Member Directory
The Journal of Molecular Diagnostics
Trainee Programs
Web Library

How to Help

Corporate Support Opportunities
Donate to AMP


AP RSS Feed Linked In FaceBook Twitter


AMP Concerned over Proposed Changes to CLFS Payment Policy

March 2014: AMP outlines significant concerns regarding sweeping changes to the Clinical Laboratory Fee Schedule (CLFS) in SGR patch legislation, submits letter to House Majority Leader.

Read the letter to Sen Harry Reid


Early Deadline for AMP 2014 Booth Space Booking Extended to May 1!

Planning to exhibit at the AMP 2014 Annual Meeting? The early booking (discounted rates!) deadline has been extended to May 1, 2014. More information....

AMP Releases White Paper on LDTs - Coins New Term

December 2013: the January 2014 JMD article proposes new, service-oriented terminology - Laboratory Developed Procedures (LDPs). "The new term accurately describes the integral expertise of the clinical laboratory professional," said Andrea Ferreira-Gonzalez, Chair, AMP LDT Working Group.

View the White Paper

View the Press Release

AMP Submits Comments to CMS on MolDX Program

October 2013: Comments detail concerns about the Palmetto Molecular Diagnostics (MolDX) Services Program and Medicare coverage as well as their impact on Gap Fill Pricing for Molecular Pathology Procedures.

View the Comments

AMP Speaks out on Reimbursement Issues

September 2013: In the past four weeks, AMP has submitted comments to the CMS and Palmetto on issues related to reimbursement and patient care. AMP will continue to advocate on behalf of its members and the field of molecular diagnostics.

View the Comments

AMPlifications - View the Most Recent Issue

View the most recent edition of AMPlifications including updates on AMP's education, advocacy, and patient care-related initiatives.

View the Newsletter


June 2013: AMP has joined the Federation of American Societies for Experimental Biology (FASEB). "Being a member of FASEB will enable AMP's voice to be even stronger," said Jennifer L. Hunt, MD, MEd, AMP President.

View the Press Release

AMP v. Myriad - Decision Reached

AMP is very pleased with the Supreme Court’s decision in the case. The Court’s decision that human genes are not patentable is a great step forward for the field of molecular pathology, for genomic science, and most important for our patients. We look forward to exciting future advancements in diagnostic testing and therapeutics that will accrue to the benefit of our patients and our field.

View the Press Release

Link to decision from Supreme Court of the United States:

Professional Societies Delineate Concerns, Offer Recommendations Regarding Interim Pricing for Molecular Tests

May 2013: A coalition representing over 120,000 medical and laboratory professionals and institutions that perform the vast majority of clinical molecular pathology testing in the United States released a joint statement regarding new Medicare prices for those tests.
More Information...

Lung Biomarker Guideline Webcast Now Available

The guideline was developed to establish standards for testing for EGFR and ALK, helping to guide targeted therapies. Pathologists are encouraged to implement the new guideline at their institutions and into their practices to help improve the effectiveness of lung cancer treatment. More information...

View the webcast (wmv file)

Download the slides

Archived News